MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Emerging inflammasome effector mechanisms
Emerging inflammasome effector mechanisms
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Emerging inflammasome effector mechanisms
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Emerging inflammasome effector mechanisms
Emerging inflammasome effector mechanisms

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Emerging inflammasome effector mechanisms
Emerging inflammasome effector mechanisms
Journal Article

Emerging inflammasome effector mechanisms

2011
Request Book From Autostore and Choose the Collection Method
Overview
Key Points In addition to mediating the maturation and secretion of the cytokines interleukin-1β (IL-1β) and IL-18, caspase 1 activation by inflammasome complexes controls a set of non-canonical effectors that might contribute to the immune response during infection and autoimmunity. These mechanisms include unconventional protein secretion, pyroptosis, regulation of metabolic pathways and restriction of bacterial replication. Caspase 1 activation in macrophages, epithelial cells and keratinocytes drives unconventional protein secretion of leaderless cytokines such as IL-1α, IL-1β and IL-18, growth factors such as fibroblast growth factor 2 and possibly damage-associated molecular patterns such as high mobility group box 1. After their release into the extracellular environment, these factors can enhance inflammatory and healing responses. Infected myeloid cells can remove intracellular replication niches for pathogens by inducing pyroptosis, a specialized caspase 1-dependent cell death programme. Pyroptosis is accompanied by osmotic lysis and the release of the intracellular content into the extracellular milieu, and this is thought (together with other inflammasome functions) to render it an inherently pro-inflammatory cell death mode. Pyroptosis is thought to confer resistance to infection with intracellular pathogens in vivo , illustrating the importance of this cell death mode for host defence. Caspase 1 can cleave poly(ADP-ribose) polymerase 1 (PARP1) and glycolysis enzymes (such as glyceraldehyde-3-phosphate dehydrogenase) to preserve ATP energy stores and to decrease the metabolic rate of infected cells. As such, caspase 1-mediated targeting of bioenergetic pathways might help to preserve cellular energy stores during infection. Caspase 1 activates lipid metabolic pathways in fibroblasts intoxicated with pore-forming toxins or infected with bacteria that produce these toxins. This leads to the repair of toxin-induced damage to the plasma membrane and promotes cell survival. In a process that proceeds independently of IL-1β and IL-18, caspase 1-mediated activation of caspase 7, an executioner caspase, contributes to the restriction of Legionella pneumophila replication in infected macrophages. In vivo studies have shown the importance of this inflammasome pathway for host defence against L. pneumophila infection in the lungs. Recent studies have shown that caspase 1 activation by inflammasomes controls a set of non-canonical effector mechanisms that might contribute to the immune response during infection and autoimmunity. These mechanisms include unconventional protein secretion, pyroptosis, regulation of metabolic pathways and restriction of bacterial replication. Caspase 1 activation by inflammasome complexes in response to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) induces the maturation and secretion of the pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18. Recent reports have begun to identify additional inflammasome effector mechanisms that proceed independently of IL-1β and IL-18. These include the induction of pyroptotic cell death, the restriction of bacterial replication, the activation of lipid metabolic pathways for cell repair and the secretion of DAMPs and leaderless cytokines. These non-canonical functions of caspase 1 illustrate the diverse mechanisms by which inflammasomes might contribute to innate immunity, repair responses and host defence.